Article
Humanization of anti‐human insulin receptor antibody for drug targeting across the human blood–brain barrier
25 Aug 2006
Abstract excerpt
A murine monoclonal antibody (MAb) to the human insulin receptor (HIR) has been engineered for use as a brain drug delivery system for transport across the human blood-brain barrier (BBB). The HIRMAb was humanized by complementarity determining region (CDR) grafting on the framework regions (FR) of the human B43 IgG heavy chain and the human REI kappa light chain. A problem encountered in the humanization process...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
